The Bone Marrow Microenvironment in Waldenstrom Macroglobulinemia

被引:9
|
作者
Agarwal, Amit [1 ]
Ghobrial, Irene M. [2 ]
机构
[1] Univ Arizona, Div Hematol Oncol, Tucson, AZ USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2013年 / 13卷 / 02期
关键词
TUMOR MICROENVIRONMENT; SOMATIC MUTATION; CELL-GROWTH; ABNORMALITY; CYTOKINES; SUGGESTS; THERAPY; MYELOMA;
D O I
10.1016/j.clml.2013.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma characterized by widespread involvement of the bone marrow (BM). The BM microenvironment serves as not only a site for disease involvement, but it also appears that the interaction of WM cells with the BM is essential for the pathogenesis of WM. The BM microenvironment consists of the cellular and noncellular compartments. The BM has been shown to regulate cell proliferation, cell cycle, and drug resistance as well as cell dissemination and cell trafficking of WM cells. A better understanding of the role of the BM microenvironment in the pathogenesis of WM can help guide better therapeutic strategies that can target the tumor clone and also regulate the BM microenvironment.
引用
收藏
页码:218 / 221
页数:4
相关论文
共 50 条
  • [31] Waldenstrom macroglobulinemia
    Gertz, Morie A.
    HEMATOLOGY, 2012, 17 : S112 - S116
  • [32] WALDENSTROM MACROGLOBULINEMIA
    FREIXA, AA
    ROS, JO
    CANALS, AM
    REVISTA CLINICA ESPANOLA, 1981, 163 (03): : 151 - 156
  • [33] Waldenstrom macroglobulinemia
    Bela, Telek
    Peter, Batar
    Laszlo, Varoczy
    Lajos, Gergley
    Laszlo, Rejto
    Robert, Szasz
    Zsofia, Miltenyi
    Zsofia, Simon
    Miklos, Udvardy
    Arpad, Illes
    ORVOSI HETILAP, 2013, 154 (50) : 1970 - 1974
  • [34] Cytokine profiles in bone marrow supernatant and peripheral blood of patients with multiple myeloma and Waldenstrom's macroglobulinemia
    Plyler, Ryan J.
    Wang, Weixin
    Ghobrial, Irene M.
    Roccaro, Aldo M.
    Korde, Neha
    Zingone, Adriana
    Landgren, Ola
    Calvo, Katherine R.
    CANCER RESEARCH, 2011, 71
  • [35] IL-21 and IL-6 Mediate Interactions Between T Cells and Malignant B Cells in the Bone Marrow Microenvironment in Waldenstrom's Macroglobulinemia
    Hodge, Lucy S.
    Ziesmer, Steve
    Secreto, Frank J.
    Yang, Zhi-Zhang
    Novak, Anne
    Gertz, Morie Abraham A.
    Ansell, Stephen M.
    BLOOD, 2012, 120 (21)
  • [36] WALDENSTROM MACROGLOBULINEMIA
    MARIA, JSD
    JIMENEZ, CB
    IZAGUERRI, RE
    RODRIGUEZ, ED
    CALOCA, JPC
    SABATE, JMB
    MIRANDA, MP
    REVISTA CLINICA ESPANOLA, 1984, 172 (01): : 1 - 3
  • [37] Expression of the kappa myelomaantigen on the cell surface of bone marrow aspirates from Waldenstrom's macroglobulinemia patients
    Jones, D. R.
    Asvadi, P.
    Raison, R. L.
    Hutchinson, A. T.
    Spencer, A.
    Dunn, R. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 221 - 222
  • [38] Severe and Irreversible Pancytopenia Associated With SARS-CoV-2 Bone Marrow Infection in a Patient With Waldenstrom Macroglobulinemia
    Velier, Melanie
    Priet, Stephane
    Appay, Romain
    Atieh, Therese
    Lepidi, Hubert
    Kaplanski, Gilles
    Jarrot, Pierre Andre
    Koubi, Marie
    Costello, Regis
    Dignat-George, Francoise
    de Lamballerie, Xavier
    Tichadou, Antoine
    Arcani, Robin
    Couderc, Anne Laure
    Touati, Julian
    Varoquaux, Arthur
    Berda-Haddad, Yael
    Venton, Geoffroy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : E503 - E505
  • [39] Waldenstrom's Macroglobulinemia Associated Bone Disease the UAMS Experience
    Papanikolaou, Xenofon
    Waheed, Sarah
    Barlogie, Bart
    Alapat, Daisy V.
    Yoon, Donghoon
    Kumar, Manoj
    Matin, Aasiya
    Zhu, Hongyun
    Harcourt, Cerisse
    Zangari, Maurizio
    BLOOD, 2014, 124 (21)
  • [40] Lytic bone lesions as a prominent feature in Waldenstrom's macroglobulinemia
    Schlesinger, N
    Neustadter, L
    Schumacher, HR
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2000, 6 (03) : 150 - 153